Sowell Financial Services LLC
Position in LGND — Ligand Pharmaceuticals Inc
CIK 1633697
NORTH LITTLE ROCK, AR
Position in LGND
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$488,991
+$186,322 QoQ
Shares Held
1,547
+2.0% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#248
of 411 holders
Holding Since
Mar 2020
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Sowell Financial Services LLC holds $6,370,982 across 18 Biotechnology names. LGND ranks #4 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,930 | $1,455,418 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
10,871 | $850,873 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
2,239 | $539,531 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
This page
|
1,547 | $488,991 | |
| 5 | RPRX |
Royalty Pharma plc
|
7,456 | $418,057 | |
| 6 | RXRX |
Recursion Pharmaceuticals, Inc.
|
110,430 | $405,278 | |
| 7 | ARGX |
Argenx SE
|
365 | $338,636 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
502 | $313,017 |
All Filings in LGND
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $488,991 | 1,547 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $302,669 | 1,516 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $251,084 | 1,328 | Shares | Sole | 2026-01-21 | |
| 2020-09-30 | $1,048 | 11 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,013 | 18 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $5,235 | 72 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||